The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended marketing authorisation for Pfizer and BioNTech’s LP.8.1-adapted monovalent Covid-19 vaccine.
The US Food and Drug Administration (FDA) has granted approval for Hikma's Tyzavan (Vancomycin Injection, USP), a ready-to-infuse vancomycin formulation.
German life science company Evotec has been awarded a $2.5m grant from The Gates Foundation (GF) to enhance the development of tuberculosis (TB) treatment regimens.
Valneva has submitted an application to the US Food and Drug Administration (FDA) seeking approval for a label extension of its chikungunya vaccine, IXCHIQ.
Novavax has announced the availability of its updated Covid-19 vaccine, known as NVX-CoV2705, at major pharmacy retailers throughout the US.
Novavax has received emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for its updated Covid-19 vaccine for individuals aged 12 years and over.
The European Commission (EC) has granted marketing authorisation for Moderna's mRESVIA (mRNA-1345) vaccine, designed for protecting individuals aged 60 and above from lower respiratory tract disease which is caused by RSV infection.
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the granting of marketing authorisation for Moderna's mRESVIA (mRNA-1345) vaccine for adults aged 60 and above.
The US Food and Drug Administration (FDA) has approved ViiV Healthcare’s Dovato (dolutegravir/lamivudine) to treat HIV-1 infection in adolescents.
Bavarian Nordic has announced the commercial availability of JYNNEOS, which is claimed to be the only FDA-approved vaccine for mpox, in the US.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.